Developer docs
API playgroundTry for free, no card

Search company profiles

Reference Analytics GmbH

Full company profile

uuid0046o3y

Namestring
Reference Analytics GmbH
Legal namestring
Conscio Pharma Austria GmbH
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Reference Analytics GmbH, now operating as Conscio Pharma Austria GmbH following a rebrand, is a GMP-certified pharmaceutical analytical services laboratory headquartered in Eisenstadt, Burgenland, Austria. The company was founded in 2012 and operates from a single location at Thomas-Alva-Edison Straße 1, AT-7000 Eisenstadt, employing a small team of approximately eight people. The business serves pharmaceutical manufacturers developing or producing small molecules, peptides, proteins, and complex drug formulations, with services spanning the full product lifecycle from method development and method transfer through validation to product release for market authorization.

The company's core technology stack is a GMP-certified analytical laboratory that applies physicochemical and chromatographic methods for drug substance and drug product characterization and quality control. Its service portfolio includes physicochemical analysis, chromatographic methods, Surface Plasmon Resonance (SPR) biosimilar analysis, nitrosamine testing (including NDSRI and Call for Review services), cleaning validation, residual solvent analysis per ICH guidelines, and validation/verification of analytical methods. Domain expertise in nitrosamines and biosimilar comparability is highlighted as a differentiator, alongside consulting for regulatory compliance challenges.

The business model is a direct B2B services model with bespoke, quote-based pricing and no publicly disclosed rates. Go-to-market relies on a regional Austria-focused distribution scope, a corporate website (consciogroup.at / consciopharma.at) for professional discovery, and direct outreach via phone (+43 (0)2682 222 77) and email (office@consciopharma.at). No intermediary, marketplace, paid marketing, or partnership channels are referenced. Ownership structure is undisclosed; the entity is a privately held Austrian GmbH with no parent company, institutional investors, or funding rounds mentioned in available data.

Short descriptiontext

Reference Analytics GmbH (rebranded Conscio Pharma Austria GmbH) is a GMP-certified Austrian analytical laboratory providing physicochemical, chromatographic, nitrosamine, biosimilar (SPR), and validation services for pharmaceutical manufacturers developing small molecules, peptides, and proteins.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEisenstadt, Austria
HQ citystring
Eisenstadt
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical analytical services, GMP-certified testing, drug substance analysis, method validation services, nitrosamine testing
Industry3 codes
PRIMARYHLAGAHAF
Small-Molecule Analytical Development & Method Validation (CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGADAC
Release Testing & Batch Certification (QC)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Testing Laboratories and Services54138
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Pharmaceutical Analytical Services
Social media profiles1 record
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Reference Analytics GmbH is a GMP-certified contract analytical laboratory providing pharmaceutical testing and analytical method services for drug substance manufacturers. Its work covers physicochemical and chromatographic characterization, method development/transfer/validation/verification, nitrosamine and NDSRI impurity testing, SPR biosimilar analysis, cleaning validation, and residual solvent analysis for small molecules, peptides, and protein-based therapeutics across the full product lifecycle from development to market release.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Reference Analytics GmbH (trading as Conscio Pharma Austria GmbH) is a GMP-certified, independent pharmaceutical analytical services company offering a comprehensive portfolio of testing and consulting services. The company provides physicochemical and chromatographic analytical methods, SPR biosimilar analysis, drug analysis, nitrosamine testing (including NDSRI characterization), method validation/verification, cleaning validation, and residual solvent analysis. Services are tailored for small molecules, peptides, proteins, and complex drug formulations throughout the entire product lifecycle from method development and transfer through validation to market release.

Product and service9 records
1Physicochemical Methods (Physikochemische Methoden)
CategoryPharmaceutical Analytical Services
Description

Physicochemical characterization and quantitative analysis of drug substances, including tests conducted under GMP guidance to support pharmaceutical development and quality control. Targeted at pharmaceutical manufacturers and sponsors needing regulated characterization data for small molecules, peptides, and proteins.

2Chromatographic Methods (Chromatographische Methoden)
CategoryPharmaceutical Analytical Services
Description

Chromatographic separation and quantification services for pharmaceutical drug substances and related impurities, executed under GMP-compliant conditions. Used by pharmaceutical companies to support identity, purity, and content testing across the product lifecycle.

3SPR Biosimilars Analysis
CategoryPharmaceutical Analytical Services
Description

Surface plasmon resonance (SPR) biosensor-based characterization and comparability analysis for biosimilar drug substances. Targets pharmaceutical manufacturers developing biosimilars who need binding and comparability data against reference products.

4Consulting
CategoryPharmaceutical Consulting
Description

Expert consulting on pharmaceutical analytical questions, supporting clients in planning, interpretation, and regulatory-relevant strategy for analytical programs. Aimed at pharmaceutical companies requiring experienced analytical and regulatory guidance.

5Drug Analysis (Arzneimittelanalyse)
CategoryPharmaceutical Analytical Services
Description

Analytical services covering the entire product lifecycle of drug substances (Arzneimittel) — from development through to market release — for small molecules, peptides, and proteins. Served to pharmaceutical manufacturers needing a single contract laboratory for ongoing GMP analytical support.

6Nitrosamine Testing
CategoryPharmaceutical Analytical Services
Description

Targeted impurity testing for nitrosamines and NDSRI (nitrosamine drug substance-related impurities) in drug substances and products, supporting regulatory risk assessment and mitigation requirements. Intended for pharmaceutical companies responding to EMA/FDA nitrosamine guidance.

7Method Validation and Verification (Validierung / Verifizierung)
CategoryPharmaceutical Analytical Services
Description

GMP-compliant method validation and verification services for pharmaceutical analytical procedures used to test drug substances. Provided to pharmaceutical manufacturers that require regulatory-grade evidence of method suitability for release and stability testing.

8Cleaning Validation (Reinigungsvalidierung)
CategoryPharmaceutical Analytical Services
Description

Analytical testing to support cleaning validation of pharmaceutical manufacturing equipment, including residue detection on production surfaces. Served to pharmaceutical manufacturers required to demonstrate acceptable cleaning procedures under GMP.

9Residual Solvent Analysis (Restlösemittel)
CategoryPharmaceutical Analytical Services
Description

Analytical determination of residual solvents in drug substances and drug products in line with ICH Q3C and pharmacopoeial requirements. Targeted at pharmaceutical manufacturers that need regulatory-grade residual solvent data for release and registration.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Clinical and bioanalytical services firm offering method development, validation, and sample analysis for pharma sponsors; overlapping GMP analytical testing capabilities in a similar scale band.

TypeBroad incumbent
Description

Global testing and quality assurance provider with pharmaceutical services including method validation, residual solvent analysis, and release testing; comparable GMP-certified offerings across a broader portfolio.

3Anacura
TypeDirect peer
Description

Belgian GMP-certified analytical services provider for pharmaceutical companies including method development, validation, and release testing; direct European competitor with similar boutique positioning.

TypeBroad incumbent
Description

Global testing giant with extensive pharmaceutical analytical services including nitrosamine and biosimilar testing; broader portfolio and far larger scale than Conscio but overlapping in CMC analytical testing for pharma.

TypeBroad incumbent
Description

Swiss-based multinational offering pharma testing, method validation, and release services across small molecules and biologics; competes for the same GMP analytical work as Conscio but at global scale.

TypeDirect peer
Description

Contract analytical and biosafety testing lab serving pharma and biotech sponsors with method validation and product release testing; closely comparable boutique GMP testing provider.

TypeRegional player
Description

European diagnostics and pharma testing network offering analytical services across multiple countries; regional overlap with Conscio's Central European pharma testing market though at considerably larger scale.

TypeBroad incumbent
Description

Global CRO/CDMO with extensive analytical chemistry, biosimilar characterization, and CMC services; significantly larger scale and broader footprint than Conscio but highly comparable analytical service line.

TypeBroad incumbent
Description

Large CRO providing bioanalytical, biosafety, and CMC services including method development and validation for pharma sponsors; a much larger incumbent competing for analytical services work.

TypeDirect peer
Description

Specialized laboratory services firm focused on pharmaceutical and medical device testing including extractables/leachables and method validation; similar-sized specialist competing for GMP analytical work.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Reference Analytics GmbH

Pharmaceutical Analytical Servicesconsciopharma.at

Reference Analytics GmbH (rebranded Conscio Pharma Austria GmbH) is a GMP-certified Austrian analytical laboratory providing physicochemical, chromatographic, nitrosamine, biosimilar (SPR), and validation services for pharmaceutical manufacturers developing small molecules, peptides, and proteins.

What Reference Analytics GmbH does

Reference Analytics GmbH, now operating as Conscio Pharma Austria GmbH following a rebrand, is a GMP-certified pharmaceutical analytical services laboratory headquartered in Eisenstadt, Burgenland, Austria. The company was founded in 2012 and operates from a single location at Thomas-Alva-Edison Straße 1, AT-7000 Eisenstadt, employing a small team of approximately eight people. The business serves pharmaceutical manufacturers developing or producing small molecules, peptides, proteins, and complex drug formulations, with services spanning the full product lifecycle from method development and method transfer through validation to product release for market authorization.

The company's core technology stack is a GMP-certified analytical laboratory that applies physicochemical and chromatographic methods for drug substance and drug product characterization and quality control. Its service portfolio includes physicochemical analysis, chromatographic methods, Surface Plasmon Resonance (SPR) biosimilar analysis, nitrosamine testing (including NDSRI and Call for Review services), cleaning validation, residual solvent analysis per ICH guidelines, and validation/verification of analytical methods. Domain expertise in nitrosamines and biosimilar comparability is highlighted as a differentiator, alongside consulting for regulatory compliance challenges.

The business model is a direct B2B services model with bespoke, quote-based pricing and no publicly disclosed rates. Go-to-market relies on a regional Austria-focused distribution scope, a corporate website (consciogroup.at / consciopharma.at) for professional discovery, and direct outreach via phone (+43 (0)2682 222 77) and email (office@consciopharma.at). No intermediary, marketplace, paid marketing, or partnership channels are referenced. Ownership structure is undisclosed; the entity is a privately held Austrian GmbH with no parent company, institutional investors, or funding rounds mentioned in available data.

Reference Analytics GmbH firmographics

Firmographics
Name
Reference Analytics GmbH
Legal name
Conscio Pharma Austria GmbH
Website
https://consciopharma.at
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Reference Analytics GmbH (rebranded Conscio Pharma Austria GmbH) is a GMP-certified Austrian analytical laboratory providing physicochemical, chromatographic, nitrosamine, biosimilar (SPR), and validation services for pharmaceutical manufacturers developing small molecules, peptides, and proteins.
Ownership category
akta.pro rank

Reference Analytics GmbH industry classification

Industry
Product category
Pharmaceutical Analytical Services
NAICS
Scientific Research and Development Services (5417), Testing Laboratories and Services (54138)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGAHAF
Small-Molecule Analytical Development & Method Validation (CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGADAC
Release Testing & Batch Certification (QC)

Keywords

  • Pharmaceutical analytical services
  • GMP-certified testing
  • Drug substance analysis
  • Method validation services
  • Nitrosamine testing

Where Reference Analytics GmbH is headquartered

Location

Headquarters

HQ city
Eisenstadt
HQ country
Austria
HQ region
Europe

Offices1 record

Markets served

Reference Analytics GmbH business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels1 record

Reference Analytics GmbH product offering

Product offering

Core offering

Reference Analytics GmbH is a GMP-certified contract analytical laboratory providing pharmaceutical testing and analytical method services for drug substance manufacturers. Its work covers physicochemical and chromatographic characterization, method development/transfer/validation/verification, nitrosamine and NDSRI impurity testing, SPR biosimilar analysis, cleaning validation, and residual solvent analysis for small molecules, peptides, and protein-based therapeutics across the full product lifecycle from development to market release.

Product overview

Reference Analytics GmbH (trading as Conscio Pharma Austria GmbH) is a GMP-certified, independent pharmaceutical analytical services company offering a comprehensive portfolio of testing and consulting services. The company provides physicochemical and chromatographic analytical methods, SPR biosimilar analysis, drug analysis, nitrosamine testing (including NDSRI characterization), method validation/verification, cleaning validation, and residual solvent analysis. Services are tailored for small molecules, peptides, proteins, and complex drug formulations throughout the entire product lifecycle from method development and transfer through validation to market release.

Differentiator

Problem solved

Functional benefit

Products and services

  • Physicochemical Methods (Physikochemische Methoden) Physicochemical characterization and quantitative analysis of drug substances, including tests conducted under GMP guidance to support pharmaceutical development and quality control. Targeted at pharmaceutical manufacturers and sponsors needing regulated characterization data for small molecules, peptides, and proteins.
  • Chromatographic Methods (Chromatographische Methoden) Chromatographic separation and quantification services for pharmaceutical drug substances and related impurities, executed under GMP-compliant conditions. Used by pharmaceutical companies to support identity, purity, and content testing across the product lifecycle.
  • SPR Biosimilars Analysis Surface plasmon resonance (SPR) biosensor-based characterization and comparability analysis for biosimilar drug substances. Targets pharmaceutical manufacturers developing biosimilars who need binding and comparability data against reference products.
  • Consulting Expert consulting on pharmaceutical analytical questions, supporting clients in planning, interpretation, and regulatory-relevant strategy for analytical programs. Aimed at pharmaceutical companies requiring experienced analytical and regulatory guidance.
  • Drug Analysis (Arzneimittelanalyse) Analytical services covering the entire product lifecycle of drug substances (Arzneimittel) — from development through to market release — for small molecules, peptides, and proteins. Served to pharmaceutical manufacturers needing a single contract laboratory for ongoing GMP analytical support.
  • Nitrosamine Testing Targeted impurity testing for nitrosamines and NDSRI (nitrosamine drug substance-related impurities) in drug substances and products, supporting regulatory risk assessment and mitigation requirements. Intended for pharmaceutical companies responding to EMA/FDA nitrosamine guidance.
  • Method Validation and Verification (Validierung / Verifizierung) GMP-compliant method validation and verification services for pharmaceutical analytical procedures used to test drug substances. Provided to pharmaceutical manufacturers that require regulatory-grade evidence of method suitability for release and stability testing.
  • Cleaning Validation (Reinigungsvalidierung) Analytical testing to support cleaning validation of pharmaceutical manufacturing equipment, including residue detection on production surfaces. Served to pharmaceutical manufacturers required to demonstrate acceptable cleaning procedures under GMP.
  • Residual Solvent Analysis (Restlösemittel) Analytical determination of residual solvents in drug substances and drug products in line with ICH Q3C and pharmacopoeial requirements. Targeted at pharmaceutical manufacturers that need regulatory-grade residual solvent data for release and registration.

Companies that use Reference Analytics GmbH

Customer profile

Segments1 record

Ideal customer profiles1 record

Reference Analytics GmbH technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Reference Analytics GmbH partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights3 records

Reference Analytics GmbH competitors and assessment

Company assessment

Direct peers

  • Celerion: Clinical and bioanalytical services firm offering method development, validation, and sample analysis for pharma sponsors; overlapping GMP analytical testing capabilities in a similar scale band.
  • Anacura: Belgian GMP-certified analytical services provider for pharmaceutical companies including method development, validation, and release testing; direct European competitor with similar boutique positioning.
  • Pacific BioLabs: Contract analytical and biosafety testing lab serving pharma and biotech sponsors with method validation and product release testing; closely comparable boutique GMP testing provider.
  • Nelson Labs: Specialized laboratory services firm focused on pharmaceutical and medical device testing including extractables/leachables and method validation; similar-sized specialist competing for GMP analytical work.

Broad incumbents

  • Intertek: Global testing and quality assurance provider with pharmaceutical services including method validation, residual solvent analysis, and release testing; comparable GMP-certified offerings across a broader portfolio.
  • Eurofins Scientific: Global testing giant with extensive pharmaceutical analytical services including nitrosamine and biosimilar testing; broader portfolio and far larger scale than Conscio but overlapping in CMC analytical testing for pharma.
  • SGS SA: Swiss-based multinational offering pharma testing, method validation, and release services across small molecules and biologics; competes for the same GMP analytical work as Conscio but at global scale.
  • WuXi AppTec: Global CRO/CDMO with extensive analytical chemistry, biosimilar characterization, and CMC services; significantly larger scale and broader footprint than Conscio but highly comparable analytical service line.
  • Charles River Laboratories: Large CRO providing bioanalytical, biosafety, and CMC services including method development and validation for pharma sponsors; a much larger incumbent competing for analytical services work.

Regional players

  • Synlab Pharma Services: European diagnostics and pharma testing network offering analytical services across multiple countries; regional overlap with Conscio's Central European pharma testing market though at considerably larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Reference Analytics GmbH social profiles

Digital presence

Reference Analytics GmbH compliance and trust

Trust signal

Compliance1 record

Reference Analytics GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Reference Analytics GmbH leadership team

Management profile

Number of profiles

Reference Analytics GmbH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Reference Analytics GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reference Analytics GmbH

What does Reference Analytics GmbH do?

Reference Analytics GmbH is a GMP-certified contract analytical laboratory providing pharmaceutical testing and analytical method services for drug substance manufacturers. Its work covers physicochemical and chromatographic characterization, method development/transfer/validation/verification, nitrosamine and NDSRI impurity testing, SPR biosimilar analysis, cleaning validation, and residual solvent analysis for small molecules, peptides, and protein-based therapeutics across the full product lifecycle from development to market release.

Is Reference Analytics GmbH a public or private company?

Reference Analytics GmbH is a private company. It is classified as unknown and is currently operating.

When was Reference Analytics GmbH founded?

Reference Analytics GmbH was founded in -1. It employs 1 to 10 people.

Where is Reference Analytics GmbH based?

Reference Analytics GmbH is headquartered in Eisenstadt, Austria, in the Europe region.

Who are Reference Analytics GmbH's main competitors?

Direct peers on record are Celerion, Anacura, Pacific BioLabs and Nelson Labs. Broad incumbents are Intertek, Eurofins Scientific, SGS SA, WuXi AppTec and Charles River Laboratories. Synlab Pharma Services is listed as a regional player.

Does Reference Analytics GmbH have an API?

No public API is recorded for Reference Analytics GmbH.

What industry is Reference Analytics GmbH in?

Reference Analytics GmbH's product category is Pharmaceutical Analytical Services. Its primary akta.pro industry code is HLAGAHAF, Small-Molecule Analytical Development & Method Validation (CMC), with a secondary code of HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales